The side effects, taken from the labels that print them

There are two minoxidils on the shelf of the internet, and almost every confused conversation about side effects comes from mixing them up. One is a liquid or a foam you can buy without asking anyone, whose warnings fit on the side of a carton. The other is a prescription tablet for dangerous high blood pressure, whose label opens with a boxed warning about the heart. They are the same molecule and they are not the same risk.

This page sets out what each label actually says, in the label's own words, and is honest about where the record stops. It contains no dose and no routine, and it is not a complete safety record: a Drug Facts panel is a summary written for a shelf, not a textbook.

What the over-the-counter panel tells you to stop for

The US Drug Facts panels on topical minoxidil carry a short list under "Stop use and ask a doctor if". It reads: "chest pain, rapid heartbeat, faintness, or dizziness occurs"; "sudden, unexplained weight gain occurs"; "your hands or feet swell"; "scalp irritation or redness occurs"; "unwanted facial hair growth occurs"; and "you do not see hair regrowth in 4 months".

Notice what kind of list that is. Three of the six are signals that a drug which widens blood vessels is having an effect beyond the patch of skin it was put on — the heart beating harder or the head going light, fluid gathering in the hands and feet, fluid showing up on the scales. One is about the skin under it. One is about hair arriving where you did not want it. And the sixth is not a safety signal at all: it is the manufacturer telling you when to conclude the product has not worked. Before that list, the same panel says to ask a doctor before use at all if "you have heart disease", and not to use it if your scalp is "red, inflamed, infected, irritated, or painful".

The scalp itself

"Scalp irritation or redness" is the one most people meet. The panel treats it as a reason to stop and ask, not as something to push through.

The usual suspect is not the minoxidil. The solution's inactive ingredients are short and specific — "alcohol (28.86% v/v), propylene glycol, purified water" — and propylene glycol is a well-known contact irritant. The foam version of the same strength has no propylene glycol at all; its inactive list runs to butylated hydroxytoluene, cetyl alcohol, citric acid, glycerin, propellants and stearyl alcohol instead. That difference is the whole reason the two formats exist side by side, and it is why "the liquid stung, so this drug is not for me" is a conclusion worth taking to a clinician rather than reaching alone. The guide to the carrier goes through both panels.

Hair where you did not put it

"Unwanted facial hair growth" is on the stop-use list, and it is not an obscure outcome. It is the same effect the drug was originally noticed for. The prescription tablet's label reports that "elongation, thickening, and enhanced pigmentation of fine body hair are seen in about 80% of patients", appearing "within 3 to 6 weeks", first "on the temples, between the eyebrows, between the hairline and the eyebrows, or in the side-burn area of the upper lateral cheek".

That figure belongs to the tablet, not the bottle, and quoting it about topical use would be dishonest. It is here because it tells you what the molecule does when it reaches the whole body, which is the reason the topical panel bothers to list facial hair at all.

The heart and the fluid signals

Chest pain, a racing heart, faintness, dizziness, swelling and sudden weight gain are grouped for a reason: they are what a vasodilator looks like when it is acting systemically. On the over-the-counter label they are a short line telling you to stop. On the prescription tablet they are the label's main subject.

The tablet's boxed warning — the most serious warning a US label carries — says minoxidil "may produce serious adverse effects", that "it can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated", and that it "should be reserved for hypertensive patients who do not respond adequately" to other treatment. It adds that the drug "must be administered under close supervision", usually with a beta-blocker to prevent a racing heart and a diuretic to prevent fluid building up, and that some patients "should be hospitalized when minoxidil is first administered". Elsewhere the same label reports pericardial effusion "in about 3% of treated patients not on dialysis".

Two honest caveats. That warning was written about people taking the tablet for severe hypertension, and the relationship between that setting and off-label use for hair is a clinical question this site cannot answer. And the reason it appears on a hair-loss website at all is that oral minoxidil for hair is prescriber-only, off-label, and increasingly talked about online as though it were an ordinary alternative to a bottle. It is not.

Sexual side effects: what the lists contain

This is one of the most searched questions about minoxidil, so it deserves a precise answer rather than a reassuring one.

What we can verify: the "stop use and ask a doctor if" list on the over-the-counter panels contains no sexual side effect, and the prescription tablet's boxed warning and warnings headings are about the heart, fluid, blood pressure and a drug interaction. That is what is printed.

What we are not going to tell you: that sexual side effects therefore do not happen, that they are rare, or any figure at all. An absence from a Drug Facts panel is not evidence of absence in a person, and we did not read a study that could support a number. Much of the confusion here comes from a different hair-loss drug entirely — a hormonal one, with a different label and a different regulatory history — being discussed in the same breath. If something has changed for you, the person to tell is a clinician, and it is worth saying out loud rather than searching for permission first. The longer version is here.

The risk that is not on any label: your cat

Nothing on a minoxidil carton warns you about the animal sleeping on your pillow, and it should.

The American Academy of Dermatology, in a page last updated in August 2026, warns that pets are poisoned when they "lick your scalp or something your head has rested on, such as a pillowcase", and that "a few drops can make a cat so sick that it requires life-saving veterinary care". Citing a case series of 211 cats and dogs seen between 2001 and 2019, it reports that "nearly all (97.8%) cats and dogs that came into contact with minoxidil were hospitalized", and that 10 of the 68 cats who came into contact with minoxidil died. The only death figure it gives is the one for cats.

We did not reach the underlying journal paper, so those figures are given exactly as the Academy gives them, and attributed to it. The practical point survives any quibble about the numbers: the exposure route is not the bottle in the cupboard. It is a treated scalp, a pillow and a cat that grooms.

What to do with any of this

None of the above is a reason to panic and none of it is advice. It is a reading list for a conversation. If something on the stop-use list has happened to you, the label's own instruction is the right one: stop and ask a doctor. If you are considering the tablet, that conversation is not optional — it is the only legal route to it, and the boxed warning is the reason why.

And if the hair loss itself arrived suddenly, in patches, or with pain, itching or scaling, the carton has already told you this is the wrong aisle. That pattern needs a diagnosis.